anti-vascular endothelial growth factor
Showing 1 - 25 of >10,000
Adult Diabetic Macular Edema and Suboptimal Response to
Not yet recruiting
- Diabetic Macular Edema
- (no location specified)
Jul 31, 2023
Macular Edema Due to Type 2 Diabetes Trial in Hangzhou (Anti-VEGF, subthreshold micropulse laser)
Recruiting
- Macular Edema Due to Type 2 Diabetes Mellitus
- Anti-VEGF
- subthreshold micropulse laser
-
Hangzhou, Zhejiang, ChinaSecond Affiliated Hospital, School of Medicine, Zhejiang Univers
Feb 26, 2023
Diabetic Macular Edema, Cataract Trial in Walnut Creek (Bevacizumab, Ranibizumab, Aflibercept)
Recruiting
- Diabetic Macular Edema
- Cataract
- Bevacizumab
- +3 more
-
Walnut Creek, CaliforniaBay Area Retina Associates
Mar 1, 2022
Exudative Age Related Macular Degeneration Trial in Winston-Salem (Ranibizumab, Photodynamic laser treatment (PDT),
Not yet recruiting
- Exudative Age Related Macular Degeneration
- Ranibizumab
- +3 more
-
Winston-Salem, North CarolinaWake Forest Health Sciences
Nov 28, 2022
Neovascular Age-related Macular Degeneration (nAMD) Trial (AR-14034 SR implant lower dose, Aflibercept Injection, Sham
Not yet recruiting
- Neovascular Age-related Macular Degeneration (nAMD)
- AR-14034 SR implant lower dose
- +3 more
- (no location specified)
Mar 3, 2023
Ocular Adverse Events in Neovascular Age-related Macular
Completed
- Age-related Macular Degeneration (AMD)
- Aflibercept
- +2 more
-
East Hanover, New JerseyNovartis Investigative Site
Dec 15, 2021
Anti-VEGF in Real-world
Recruiting
- Neovascular Age-related Macular Edema
- +5 more
- Ranibizumab
- +2 more
-
Beijing, Beijing, ChinaWen-Bin Wei
Feb 2, 2022
Retinal Vein Occlusion Trial in Winston-Salem (Aflibercept Ophthalmic)
Recruiting
- Retinal Vein Occlusion
- Aflibercept Ophthalmic
-
Winston-Salem, North CarolinaWake Forest Health Sciences
Jan 5, 2022
Age Related Macular Degeneration Trial in Xuzhou (recombinant anti-vascular endothelial growth factor (VEGF) humanized mAb
Recruiting
- Age Related Macular Degeneration
- recombinant anti-vascular endothelial growth factor (VEGF) humanized monoclonal antibody ophthalmic injection
-
Xuzhou, Jiangsu, ChinaXuZhou Central Hospital
Feb 7, 2022
Intravitreal Injection Site and Perceived Pain
Recruiting
- Pain
- Intravitreal injection site
-
Galveston, TexasUniversity of Texas Medical Branch
Jan 19, 2023
Retinal Pigment Epithelium Detachment in Neovascular Age-related
Active, not recruiting
- Neovascular Age-related Macular Degeneration
- Anti-vascular endothelial growth factor therapy
-
Krasnodar, Russian FederationThe S.N. Fyodorov Eye Microsurgery State Institution
Jan 12, 2022
Recurrent Brain Tumor Trial in Houston (biological, other, radiation)
Active, not recruiting
- Recurrent Brain Neoplasm
- Bevacizumab
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Dec 9, 2022
Macular Disease Trial in Omaha
Suspended
- Macular Disease
-
Omaha, Nebraska
- +1 more
Sep 16, 2022
Eyes That Do Not Meet Eligibility Criteria of Clinical Trials on
Completed
- Age-related Macular Degeneration
- Intravitreal anti-vascular endothelial growth factor injection
-
Seoul, Korea, Republic ofJae Hui Kim
Apr 6, 2021
Recurrent Fallopian Tube Carcinoma, Recurrent Ovarian Carcinoma, Recurrent Primary Peritoneal Carcinoma Trial in Phoenix,
Recruiting
- Recurrent Fallopian Tube Carcinoma
- +2 more
- Bevacizumab
- +4 more
-
Phoenix, Arizona
- +2 more
Jun 27, 2022
Platinum-Resistant Fallopian Tube Carcinoma, Platinum-Resistant Ovarian Carcinoma, Platinum-Resistant Primary Peritoneal
Completed
- Platinum-Resistant Fallopian Tube Carcinoma
- +8 more
- Bevacizumab
- Irinotecan Sucrosofate
-
Chicago, IllinoisNorthwestern University
Dec 21, 2022
Exudative Age-related Macular Degeneration Trial (intravitreal injection)
Completed
- Exudative Age-related Macular Degeneration
- intravitreal injection
- (no location specified)
Apr 19, 2022
Diabetic Macular Edema, Cataract Trial in Atlanta (Aflibercept injected Pre- and Post-operatively, Aflibercept injected
Withdrawn
- Diabetic Macular Edema
- Cataract
- Aflibercept injected Pre- and Post-operatively
- Aflibercept injected intraoperatively
-
Atlanta, Georgia
- +1 more
Dec 23, 2020
Ovarian Clear Cell Adenocarcinoma, Platinum-Sensitive Ovarian Carcinoma, Recurrent Endometrial Serous Adenocarcinoma Trial in
Not yet recruiting
- Ovarian Clear Cell Adenocarcinoma
- +14 more
- Anti-CD40 Agonist Monoclonal Antibody CDX-1140
- +4 more
-
Buffalo, New York
- +1 more
Dec 16, 2022
Neovascular Age-related Macular Degeneration(nAMD) Trial in Shanghai, Tianjin (HG202)
Not yet recruiting
- Neovascular Age-related Macular Degeneration(nAMD)
- HG202
-
Shanghai, Shanghai, China
- +1 more
Sep 4, 2023
Resectable Hepatocellular Carcinoma, Stage I Hepatocellular Carcinoma AJCC v8, Stage IA Hepatocellular Carcinoma AJCC v8 Trial
Recruiting
- Resectable Hepatocellular Carcinoma
- +4 more
- Atezolizumab
- +2 more
-
Houston, Texas
- +1 more
Oct 12, 2022
Fallopian Tube Carcinosarcoma, Fallopian Tube Adenocarcinoma, Fallopian Tube Serous Adenocarcinoma Trial in Buffalo
Not yet recruiting
- Fallopian Tube Carcinosarcoma
- +10 more
- Bevacizumab
- +4 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Dec 29, 2022